Abivax ABVX
NASDAQ ABVX
$91.44 +1.44 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Abivax (ABVX) Long-Term Debt Repayments (2024 - 2025)

Updated

Abivax's Long-Term Debt Repayments came in at -$62.75 billion for Q4 2025, compared with -$9.34 billion a year earlier.

Analysis

Abivax (ABVX) Long-Term Debt Repayments (2024 - 2025) Analysis & Trends

For FY2025, Abivax's Long-Term Debt Repayments was -$60.92 billion.

  • Going back by year, Long-Term Debt Repayments was -$9.47 billion in FY2024, -$29.41 billion in FY2023 and -$9.92 billion in FY2022.
  • The Q4 2025 figure represents the lowest quarterly Long-Term Debt Repayments in data going back to Q1 2024.
  • Business Quant data shows ABVX's Long-Term Debt Repayments at -$6.33 million (Q3 2025), -$6.15 million (Q2 2025) and -$3.9 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Abivax 7.07 Bn 4.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -62.75 Bn
Sep 30, 2025 -6.33 Mn
Jun 30, 2025 -6.15 Mn
Mar 31, 2025 -3.90 Mn
Dec 31, 2024 -9.34 Bn
Sep 30, 2024 -2.40 Mn
Jun 30, 2024 -2.36 Mn
Mar 31, 2024 -2.38 Mn
API Access

Abivax Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ABVX&period=max&api_key=YOUR_API_KEY